Intuitive Surgical announces U.S. FDA cleared da Vinci 5 system

Intuitive announced that the U.S. Food and Drug Administration, FDA, has cleared the da Vinci 5 system for certain cardiac procedures, including mitral valve repair and IMA mobilization for cardiac revascularization. “Opening the chest to perform surgical procedures can involve significant pain, high risk of complications, and long recovery times that can affect patients’ physical and psychological wellbeing,” said Intuitive chief executive officer Dave Rosa. “This clearance reflects our commitment to advancing minimally invasive cardiac surgery so more surgeons and care teams can pursue improved outcomes for their patients.”